Postpartum mood disorders

Primary Psychiatry

Volumn 11, Issue 9, 2004, Pages 20-21

  Clayton, Anita H ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN 1 RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

BEHAVIOR THERAPY; BIPOLAR MANIA; BREAST MILK; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; DELIVERY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DRUG EXCRETION; DRUG MILK LEVEL; ELECTROCONVULSIVE THERAPY; EPIDEMIOLOGICAL DATA; FOLLOW UP; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INCIDENCE; LACTATION; MAJOR DEPRESSION; MOOD DISORDER; MORBIDITY; PATIENT REFERRAL; PRENATAL CARE; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; PSYCHOTHERAPY; PUERPERAL DEPRESSION; PUERPERAL PSYCHOSIS; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REMISSION; RISK BENEFIT ANALYSIS; RISK FACTOR; SHORT SURVEY; SIDE EFFECT; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 4944255488     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (18)

1. Green J, Murray D. The use of the Edinburgh Postnatal Depression Scale in research to explore the relationship between antenatal and postnatal dysphoria. In: Cox J, Holden J, eds. Perinatal Psychiatry. London, UK: Gaskell; 1994.
2. Cohen LS. Pharmacologic treatment of depression in women: PMS, pregnancy, and the postpartum period. Depress Anxiety. 1998;8(suppl 1):18-26.
3. O'Hara MW, Swain AM. Rates and risk of postpartum depression: a meta-analysis. Int Rev Psychiatry. 1996;8:37-54.
4. Paykel ES, Emms EM, Fletcher J, Rassaby ES. Life events and social support in puerperal depression. Br J Psychiatry. 1980;136:339-346.
5. Buist A. Childhood abuse, parenting and postpartum depression. Aust N Z J Psychiatry. 1998;32(4):479-487.
6. Boyce P, Hickie I, Parker G. Parents, partners or personality? Risk factors for post-natal depression. J Affect Disord. 1991;21(4):245-255.
7. Boyce PM. Risk factors for postnatal depression: a review and risk factors in Australian populations. Arch Women Ment Health. 2003;6(suppl 2):S43-S50.
8. O'Hara MW. Postpartum Depression: Causes and Consequences. New York, NY: Springer-Verlag; 1995.
9. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
10. Gabbe S, Niebyl J, Simpson J. Obstetrics: Normal and Problem Pregnancies. New York, NY: Churchill Livingstone; 1996.
11. Josefsson A, Angelsioo L, Berg G, et al. Obstetric, somatic, and demographic risk factors for postpartum depressive symptoms. Obstet Gynecol. 2002;99(2):223-228.
12. Morris-Rush JK, Freda MC, Bernstein PS. Screening for postpartum depression in an inner-city population. Am J Obstet Gynecol. 2003;188(5):1217-1219.
13. Campbell SB, Cohn JF, Meyers T. Depression in first-time mothers: mother-infant interaction and depression chronicity. Dev Psychol. 1995;31:340-357.
14. Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychoses. Br J Psychiatry. 1987;150:662-73. Erratum in: Br J Psychiatry. 1987;151:135.
15. Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychoses. Br J Psychiatry. 1987;150:662-73. Erratum in: Br J Psychiatry. 1987;151:135.
16. O'Hara MW, Stuart S, Gorman LL, Wenzel A. Efficacy of interpersonal psychotherapy for postpartum depression. Arch Gen Psychiatry. 2000;57(11):1039-1045.
17. Appleby L, Warner R, Whitton A, Faragher B. A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ. 1997;314(7085):932-936.
18. Cohen LS, Viguera AC, Bouffard SM, et al. Venlafaxine in the treatment of postpartum depression. J Clin Psychiatry. 2001;62(8):592-596.